In the present study, through whole-exome sequencing (WES), we identified the clonal acquisition of a novel RAC1 (P34R) mutation in the recurrent tumor of a PTC patient (BRAFT599del;K601N) that progressed under dabrafenib treatment. This evidence concerns the gene RAC1 and neoplasm.